Discussing the realities today for patients who are dealing with complex cancer diagnoses.

Syneos Health experts look at how a recent ICER draft report on Sickle Cell Disease could influence how stakeholders feel about the value of a product prior to approval.

How can we use technology and increasing volumes of data to change the future of human health and healthcare as we move forward into 2023 and beyond?

How are investors responding to recent challenges in the biotech public equity market?

In this webinar, we discuss strategic and operational implications for the biotech C-suite and share perspectives on how companies can succeed in an increasingly competitive...

Experts outline why using a “pathfinder” to deploy resources can help with product launch success.